# Leading Capital

> Leading Capital is a VC fund backing Artificial Intelligence. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 10
- Last investment: May 2026
- Lead investor: 60%
- Last updated: Aug 2026
- Website: http://www.leadingcapital.com.cn/

Leading Capital is a VC fund in Beijing focused on Artificial Intelligence and Manufacturing. Leadingoptics capital is a professional investment fund managers and integrated investment management group. Leadingoptics capital headquarters management platform, including Shanghai Li Ding Investment Management Company, Beijing Li Ding Industrial Venture Management Center (limited partnership) and Shenzhen City tripod Fund Management Co.,Ltd., and has regional management platform in Guangzhou, Zhengzhou and other places. Leadingoptics capital to meet the need to invest in different industries and different stages of development of enterprises, in cooperation with the government and financial and investment institutions, including the establishment of venture capital funds (VC), equity funds (PE) and mergers and acquisitions fund (M & A) and other types of private equity investment funds, assets under management more than 6 billion yuan.

## Contacts

5 contacts available for Leading Capital. Shizune tracks 1 team members at Leading Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/leadingoptics-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 4 | 40% |
| Manufacturing | 3 | 30% |
| Energy | 1 | 10% |
| Mining | 1 | 10% |
| Battery | 1 | 10% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 7 | 70% |
| Seed | 1 | 10% |
| Series B | 1 | 10% |
| Series C | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Wu Chaoyang | Chairman | 1 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Moffett AI | MoXin is an AI chip designer, providing terminal and cloud AI chip acceleration solutions. | $147.5M | Series C | May 28, 2026 |  |
| Qiyunfang | Qiyunfang is an enterprise cloud platform. |  | Series B | Apr 20, 2026 |  |
| Nanke Tianrun | Nanke Tianrun focuses on the R&D and industrialization of core materials for solid-state batteries. |  | Series A | Mar 05, 2026 |  |
| Chuangyi Bocheng | Chuangyi Bocheng is a high-tech enterprise specializing in the research, development, and implementation of artificial intelligence applications tailored for financial scenarios. The company is dedicated to leveraging cutting-edge technologies such as machine learning, big data analytics, and intelligent automation to enhance decision-making,optimize operations, and drive innovation across the financial industry. |  | Series A | Nov 05, 2025 |  |
| Elu.AI | Elu.AI specializes in the design, manufacture, and deployment of intelligent robots and AI agent solutions. |  | Seed | Mar 25, 2025 |  |
| Beichen Innovation | Beichen Innovation manufactures lithium batteries and cathode materials and offers cathode process solutions to lithium iron phosphate cathode material producers. | $14.1M | Series A | Nov 28, 2023 |  |
| Carbon Energy Technology | Carbon Energy Technology develops technology for carbon utilization and its commercialization. | $13.8M | Series A | Sep 01, 2023 |  |
| Demark | Demark Seiko is a domestic high-end parts supplier that primarily provides high-precision parts, medium and large parts, and functional structural components to firms in the photovoltaic, wind power, semiconductor, heavy industry, and other industries. | $13.9M | Series A | Jul 04, 2023 |  |
| MaxSense Technology | MaxSense Technology is an autonomous driving and industrial operation optimization developer company. |  | Series A | Aug 17, 2022 |  |
| Anda Biopharma | Anda Biopharma integrates high-end talents and technologies in tumor genomics, immunology, and vaccinology research, and is committed to developing new personalized therapeutic vaccines for tumors |  | Series A |  |  |

10 of 10 investments shown.

## Co-investors
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 1 deal together
- Broadcom Ventures — VC Fund, 1 deal together
- [Cyber Creation Ventures (CCV)](https://shizune.co/investors/profile/china-creation-ventures) — VC Fund, 1 deal together
- [Creation Venture Partners](https://shizune.co/investors/profile/creation-venture-partners) — VC Fund, 1 deal together
- [DFJ DragonFund](https://shizune.co/investors/profile/dfj-dragonfund) — VC Fund, 1 deal together
- [Galaxy Capital](https://shizune.co/investors/profile/galaxy-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Leading Capital invest in?

Leading Capital invests primarily in Artificial Intelligence, Manufacturing and Energy startups, most often at Series A and Seed stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Leading Capital?

Public channels for Leading Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Leading Capital?

The team at Leading Capital includes Wu Chaoyang (Chairman). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co